# Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder

> **NCT02737020** · PHASE4 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 60 (estimated)

## Conditions studied

- Attention Deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Rhodiola
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02737020
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737020, "Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02737020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*